Patient access to innovative new therapies requires us to reimagine the supply chain and how it integrates advanced ...

The evolution of clinical trials shows that although much has changed, several things remain the same. When a patient expresses interest in a trial, they complete an informed consent process, and ...

Traditional trial start-up workflows often follow a sequential path, from feasibility to contracting, then regulatory ...

BioVie Inc. presented its SUNRISE-PD trial's patient-centric design at the ATMRD Congress, enhancing access for Parkinson's patients. BioVie Inc. announced that a poster on its SUNRISE-PD Phase 2 ...

LyfeSci Research & Innovation, a full-service clinical research organization (CRO), announces the acquisition of Clinically ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Ask a group of people what they believe the most expensive ...

As healthcare institutions deal with meager financial returns across their systems, they are focusing on “back-to-basics” projects, according to Michael Fischer, development manager at Seattle-based ...

With the passage of the Patient Protection Affordable Care Act, organizations are looking to have their technology better support and enhance the patient and family engagement. To achieve this goal, ...

Creative-problem solving solutions, encapsulated in ‘design thinking’ methodology in which patient-centered approach to innovation of MCS systems necessitates a participatory co-design process that ...

As part of a patient-support program (PSP) for those with neuroendocrine tumors (NETs), Ipsen offers Somatuline Autogel/Somatuline Depot (lanreotide) in a prefilled syringe. The company recently ...

CARSON CITY, Nev., June 26, 2025 (GLOBE NEWSWIRE) -- BioVie Inc. (BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for the treatment of neurological and ...